牙种植治疗中软组织增量干预的结局指标与评估方法:近10年已发表临床研究的系统评价
该系统评价遵循PRISMA 2020并在PROSPERO注册(CRD42021252214),检索近10年牙种植软组织增量临床研究,纳入92篇文献(39篇随机对照试验、20篇非随机对照试验、33篇病例系列研究)。结局指标分为研究者评价指标与患者报告结局指标(PROMs),临床法评估的面部黏膜厚度(22.83%)等为最常报告的主要结局;PROMs报告不足,未来临床研究应将其视为方法学组成部分。
要点
- 近10年牙种植软组织增量临床研究逐渐增多,临床结局指标报告最多。
- 最常报告的主要结局为临床法评估的面部黏膜厚度(22.83%)与角化黏膜宽度(19.57%)。
- PROMs总体报告不足,作者认为未来临床研究应将其视为方法学组成部分。
核心结论
- 近10年牙种植软组织增量临床研究逐渐增多,临床结局指标报告最多,领域趋势显示从传统临床评估方法转向数字化技术。
- PROMs总体报告不足,但作者认为应将其视为未来临床研究的方法学组成部分。
研究设计与样本
- 遵循PRISMA 2020的系统评价,方案在PROSPERO注册(CRD42021252214),检索并纳入符合预设标准的文献。
- 共纳入92篇文章,其中39篇报告随机对照试验、20篇报告非随机对照试验、33篇报告病例系列研究。
- 提取结局指标相关数据,描述每项结局的具体方法与评估时机,对结局指标进行分类并计算主要结局的报告频率。
- 对单篇文献及主要结局进行偏倚风险评估。
主要发现
- 结局指标分为研究者评价结局指标(临床、数字影像、美学、组织学、生物标志物与安全性)和患者报告结局指标(PROMs)。
- 临床结局是最常报告的类型;考虑所有类别,最常报告的主要结局为临床法评估的面部黏膜厚度(22.83%)、临床法评估的面部角化黏膜宽度(19.57%)、临床法评估的面部黏膜边缘位置/退缩(18.48%)、数字影像法评估的面部黏膜厚度(11.96%)、数字影像法评估的面部软组织体积(9.78%)和临床法评估的嵴上组织高度(9.78%)。
- 未观察到临床研究类型或质量(偏倚水平)与主要结局选择之间存在可辨别的关联模式。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: The aim of the study was to identify and report outcome measures and methods of assessment on soft-tissue augmentation interventions in the context of dental implant therapy reported in clinical studies published in the last 10 years. MATERIAL AND METHODS: The protocol of this PRISMA 2020-compliant systematic review was registered in PROSPERO (CRD42021252214). A literature search was conducted to identify articles that met the pre-established eligibility criteria. Data of interest, with an emphasis on outcome measures, were extracted. For each outcome, specific methods and timing of assessment were described in detail. Following a critical qualitative analysis of the data, outcome measures were categorized. Primary outcomes were identified and the frequency of reporting in the selected articles was calculated. Additionally, risk of bias assessments were performed for individual articles and primary outcomes. RESULTS: Ninety-two articles, of which 39 reported randomized controlled trials (RCTs), 20 reported non-RCTs, and 33 reported case series studies, were selected. Outcome measures were categorized into either investigator-evaluated outcome measures (i.e., clinical, digital imaging, esthetic, histologic, biomarker, and safety) or patient-reported outcome measures (PROMs). Clinical outcomes were the most frequently reported type of outcome. Considering all categories, the most frequently reported primary outcomes were facial mucosa thickness assessed with clinical methods (22.83%), facial keratinized mucosa width assessed with clinical methods (19.57%), facial mucosal margin position/recession assessed with clinical methods (18.48%), facial mucosa thickness assessed with digital imaging methods (11.96%), facial soft-tissue volume assessed with digital imaging methods (9.78%), and supracrestal tissue height assessed with clinical methods (9.78%). No distinguishable patterns of association between specific types or quality (level of bias) of clinical studies and the choice of primary outcomes were observed. CONCLUSION: Clinical research on peri-implant soft-tissue augmentation has progressively increased in the last 10 years. Although clinical outcome measures were the most frequently reported outcomes in the selected literature, trends in the field are indicative of a shift from traditional clinical assessment methods to the use of digital technologies. PROMs were generally underreported but should be considered an integral methodological component in future clinical studies.
引用
- Avila-Ortiz G, Couso-Queiruga E, Pirc M, et al. Outcome measures and methods of assessment of soft-tissue augmentation interventions in the context of dental implant therapy: A systematic review of clinical studies published in the last 10 years. Clin Oral Implants Res. 2022. PMID: 35343615. doi:10.1111/clr.13927
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。